Pharmaceutical Contract Sales Outsourcing (CSO) Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

Pharmaceutical Contract Sales Outsourcing (CSO) Market Size
The global Pharmaceutical Contract Sales Outsourcing (CSO) market is projected to grow from US$ 8162.8 million in 2023 to US$ 12310 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-18G13123/Global_Pharmaceutical_Contract_Sales_Outsourcing_CSO_Market_Research_Report_2023

Pharmaceutical Contract Sales Outsourcing (CSO) Market
Pharmaceutical Contract Sales Outsourcing (CSO), also known as Contract Sales Organization (CSO),means an Entity commonly and primarily known as a "contract sales organization" that is engaged primarily in the business of promoting products for third parties and is not, and is not a direct or indirect affiliate of, an entity commonly and primarily known as a "pharmaceutical", "biopharmaceutical" or "biotechnology" company; and (2) "Contract Sales Arrangement" shall mean an arrangement (that is terminable by the Company within three years without payment or penalty) between the Company and a Contract Sales Organization under which such Contract Sales Organization (A) would promote (and would only be granted such rights as are necessary to promote) a Company Pharmaceutical Product for a fee (which may be fixed or based upon a percentage of revenues or otherwise) but (B) would not be granted any research, development, manufacturing, sublicensing or other rights with respect to such Company Pharmaceutical Product or with respect to any Intellectual Property underlying or related to such Company Pharmaceutical Product except as necessary for the purpose of clause "(A)".
The Pharmaceutical Contract Sales Outsourcing (CSO) market covers Personal Promotion, Non-personal Promotion, Others, etc. The typical players include IQVIA, PHOENIX Group, Amplity Health, Ashfield Engage (Inizio), Syneos Health, EVERSANA, CMIC Group, EPS Corporation, etc.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-18G13123/Global_Pharmaceutical_Contract_Sales_Outsourcing_CSO_Market_Research_Report_2023

Segment by Type
• Personal Promotion
• Non-personal Promotion
• Others

Segment by Application
• Pharmaceutical Company
• Biotechnology Company
• Generic Company
• Others

By Company
China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, Ashfield Engage (Inizio), Amplity Health, Sinco Pharma, Syneos Health, EPS Corporation, Uniphar Group, CMIC Group, SciClone Pharmaceuticals, China Pioneer Pharma, Promoveo Health, CSO Pharmitalia, GTS Solution, QFR Solutions

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-18G13123/global-pharmaceutical-contract-sales-outsourcing-cso

Get similar reports
1. https://reports.valuates.com/market-reports/QYRE-Auto-17B15435/global-pharmaceutical-contract-sales-organization-cso
2. https://reports.valuates.com/market-reports/QYRE-Auto-25A1615/global-pharmaceutical-solid-dosage-contract-manufacturing
3. https://reports.valuates.com/market-reports/QYRE-Auto-11T6075/global-pharmacovigilance-outsourcing

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.